SpaceX Stock: 3 Reasons I Am Not Buying the Dip

SpaceX shares were hit after its Q2 update, despite revenue jumping 92% YoY to $7.8B, with the net loss narrowing to $541M from $1.0B. The article highlights $15.8B of Q2 capex tied to AI (up 2x QoQ and >6x other segments) and management’s plan for continued heavy spend, implying limited near-term ROI. It also flags a $60B all-stock acquisition of Cursor (share dilution risk) plus Aug. 6 lockup expiration and stresses valuation—$1.5T market cap on quarterly revenue and a P/S of 73.4 versus a typical <2—arguing the stock could fall further.

Analysis

SPCX looks more like a financing/liquidity story than a clean fundamental re-rate. Heavy AI capex, an all-stock acquisition, and lockup supply create a classic setup where equity holders fund ambition before the market can verify returns, so the marginal buyer is paying for optionality while dilution does the near-term damage. That usually compresses multiples faster than top-line growth can offset.

The immediate risk is mechanical over the next days to 4-6 weeks: insider selling, secondary supply, and reduced underwriter support can pressure the tape even if operating KPIs hold up. Over 1-3 months, the market will focus on whether AI spend is converting into revenue per dollar of capex or just raising the equity hurdle rate; if conversion remains unclear, downside can continue in installments. Over 6-18 months, the thesis only breaks if management can either slow capex materially or show clear free-cash-flow leverage from AI/connectivity.

The contrarian miss is that story stocks can stay expensive longer than value screens suggest if float is tight and growth remains unusually fast, so an aggressive short too early can be painful. The cleaner read is that the burden of proof has shifted: this is no longer a "how big is the TAM" debate, it is a "what is the payback period" debate. Until management proves that payback, rallies should be treated as supply into strength rather than the start of a durable re-rating.

Key Decisions for Investors

• If borrow is available, initiate a short SPCX position on any post-lockup bounce; use a 3-6 month horizon and cover if the stock reclaims its post-earnings high on materially better free-cash-flow guidance.
• Prefer defined-risk downside exposure via SPCX 3-6 month put spreads, ideally 10-15% OTM, to express the view that dilution and supply overhang will matter before AI monetization does.
• Pair trade: long NVDA / short SPCX at roughly equal dollar risk to express the market's split between proven AI monetization and speculative AI capex; the thesis breaks if SPCX shows accelerating revenue per unit of spend.
• Set an alert for any insider sale filings or secondary offering language over the next 4-8 weeks; those are the highest-probability catalysts for another leg lower.
• Do not buy the dip until management can show capex intensity flattening and a clear path to sustained positive FCF; absent that, the risk/reward remains skewed against fresh longs.